In vitro activity of aryl-thiazole derivatives against Schistosoma mansoni schistosomula and adult worms

Article abstract of DOI:10.1371/journal.pone.0225425

Schistosomiasis is caused by a trematode of the genus Schistosoma and affects over 200 million people worldwide. The only drug recommended by the World Health Organization for treatment and control of schistosomiasis is praziquantel. Development of new drugs is therefore of great importance. Thiazoles are regarded as privileged structures with a broad spectrum of activities and are potential sources of new drug prototypes, since they can act through interactions with DNA and inhibition of DNA synthesis. In this context, we report the synthesis of a series of thiazole derivatives and their in vitro schistosomicidal activity by testing eight molecules (NJ03-08; NJ11-12) containing thiazole structures. Parameters such as motility and mortality, egg laying, pairing and parasite viability by ATP quantification, which were influenced by these compounds, were evaluated during the assays. Scanning electron microscopy (SEM) was utilized for evaluation of morphological changes in the tegument. Schistosomula and adult worms were treated in vitro with different concentrations (6.25 to 50 μM) of the thiazoles for up to 5 and 3 days, respectively. After in vitro treatment for five days with 6.25 μM NJ05 or NJ07 separately, we observed a decrease of 30percent in schistosomula viability, whilst treatment with NJ05+NJ07 lead to a reduction of 75percent in viability measured by ATP quantitation and propidium iodide labeling. Adult worms’ treatment with 50 μM NJ05, NJ07 or NJ05 + NJ07 showed decreased motility to 30–50percent compared with controls. Compound NJ05 was more effective than NJ07, and adult worm viability after three days was reduced to 25percent in parasites treated with 50 μM NJ05, compared with a viability reduction to 40percent with 50 μM NJ07. SEM analysis showed severe alterations in adult worms with formation of bulges and blisters throughout the dorsal region of parasites treated with NJ05 or NJ07. Oviposition was extremely affected by treatment with the NJ series compounds; at concentrations of 25 μM and 50 μM, oviposition reached almost zero with NJ05, NJ07 or NJ05 + NJ07 already at day one. Tested genes involved in egg biosynthesis were all confirmed by qPCR as downregulated in females treated with 25 μM NJ05 for 2 days, with a significant reduction in expression of p14, Tyrosinase 2, p48 and fs800. NJ05, NJ07 or NJ05 +NJ07 treatment of HEK293 (human embryonic cell line) and HES (human epithelial cell line) showed EC50 in the range of 18.42 to 145.20 μM. Overall, our results demonstrate that those molecules are suitable targets for further development into new drugs for schistosomiasis treatment, although progress is needed to lessen the cytotoxic effects on human cells. According to the present study, thiazole derivatives have schistosomicidal activities and may be part of a possible new arsenal of compounds against schistosomiasis.

Full text of DOI:10.1371/journal.pone.0225425

RESEARCH ARTICLE
In vitro activity of aryl-thiazole derivatives
against Schistosoma mansoni schistosomula
and adult worms
1
,2
1,2
1
3,4
Adriana S. A. Pereira , Gilbert O. Silveira , Murilo S. AmaralID , Sinara M. V. Almeida
,
3
3
1,2
Jamerson F. Oliveira , Maria C. A. Lima , Sergio Verjovski-AlmeidaID
*
1
Instituto Butantan, São Paulo, Brasil, 2 Departamento de Bioqu ´ı mica, Instituto de Qu ´ı mica, Universidade
de São Paulo, São Paulo, Brasil, 3 Universidade Federal de Pernambuco, Departamento de Antibi o´ ticos,
Recife, Pernambuco, Brasil, 4 Universidade de Pernambuco, Campus Garanhuns, Garanhuns,
Pernambuco, Brasil
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
* verjo@iq.usp.br
Abstract
Schistosomiasis is caused by a trematode of the genus Schistosoma and affects over 200
million people worldwide. The only drug recommended by the World Health Organization for
treatment and control of schistosomiasis is praziquantel. Development of new drugs is
therefore of great importance. Thiazoles are regarded as privileged structures with a broad
spectrum of activities and are potential sources of new drug prototypes, since they can act
through interactions with DNA and inhibition of DNA synthesis. In this context, we report the
synthesis of a series of thiazole derivatives and their in vitro schistosomicidal activity by test-
ing eight molecules (NJ03-08; NJ11-12) containing thiazole structures. Parameters such as
motility and mortality, egg laying, pairing and parasite viability by ATP quantification, which
were influenced by these compounds, were evaluated during the assays. Scanning electron
microscopy (SEM) was utilized for evaluation of morphological changes in the tegument.
Schistosomula and adult worms were treated in vitro with different concentrations (6.25 to
OPEN ACCESS
Citation: Pereira ASA, Silveira GO, Amaral MS,
Almeida SMV, Oliveira JF, Lima MCA, et al. (2019)
In vitro activity of aryl-thiazole derivatives against
Schistosoma mansoni schistosomula and adult
worms. PLoS ONE 14(11): e0225425. https://doi.
org/10.1371/journal.pone.0225425
Editor: Josu e´ de Moraes, Universidade Guarulhos,
BRAZIL
Received: July 26, 2019
Accepted: November 5, 2019
Published: November 25, 2019
50 μM) of the thiazoles for up to 5 and 3 days, respectively. After in vitro treatment for five
days with 6.25 μM NJ05 or NJ07 separately, we observed a decrease of 30% in schistoso-
mula viability, whilst treatment with NJ05+NJ07 lead to a reduction of 75% in viability mea-
sured by ATP quantitation and propidium iodide labeling. Adult worms’ treatment with 50 μM
NJ05, NJ07 or NJ05 + NJ07 showed decreased motility to 30–50% compared with controls.
Compound NJ05 was more effective than NJ07, and adult worm viability after three days
was reduced to 25% in parasites treated with 50 μM NJ05, compared with a viability reduc-
tion to 40% with 50 μM NJ07. SEM analysis showed severe alterations in adult worms with
formation of bulges and blisters throughout the dorsal region of parasites treated with NJ05
or NJ07. Oviposition was extremely affected by treatment with the NJ series compounds; at
concentrations of 25 μM and 50 μM, oviposition reached almost zero with NJ05, NJ07 or
NJ05 + NJ07 already at day one. Tested genes involved in egg biosynthesis were all con-
firmed by qPCR as downregulated in females treated with 25 μM NJ05 for 2 days, with a sig-
nificant reduction in expression of p14, Tyrosinase 2, p48 and fs800. NJ05, NJ07 or NJ05
+NJ07 treatment of HEK293 (human embryonic cell line) and HES (human epithelial cell
Peer Review History: PLOS recognizes the
benefits of transparency in the peer review
process; therefore, we enable the publication of
all of the content of peer review and author
responses alongside final, published articles. The
editorial history of this article is available here:
https://doi.org/10.1371/journal.pone.0225425
Copyright: © 2019 Pereira et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
1 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Funding: This work was supported in by a grant
from Funda c¸ ão de Amparo à Pesquisa do Estado
de São Paulo (FAPESP) to SVA. This study was
financed in part by Coordena c¸ ão de
line) showed EC50 in the range of 18.42 to 145.20 μM. Overall, our results demonstrate that
those molecules are suitable targets for further development into new drugs for schistosomi-
asis treatment, although progress is needed to lessen the cytotoxic effects on human cells.
According to the present study, thiazole derivatives have schistosomicidal activities and
may be part of a possible new arsenal of compounds against schistosomiasis.
Aperfei c¸ oamento de Pessoal de N ´ı vel Superior
(
CAPES), Brazil – Finance Code 001. Fellowships
from FAPESP have supported ASAP (2016/10046-
) and GOS (2018/24015-0). MSA was supported
6
by Funda c¸ ão Butantan. SMVA, JFO and MCAL were
supported by fellowship PNPD from CAPES,
process BCT-0149-4.03/17. SVA was also
supported by institutional funds from Funda c¸ ão
Butantan. SVA is the recipient of an established
investigator fellowship award from Conselho
Nacional de Desenvolvimento Cientifico e
Introduction
Schistosomiasis is recognized as a serious public health problem in the world [1,2]. According
to the World Health Organization (WHO), it is estimated that more than 206 million people
worldwide are affected by the disease and that more than 700 million people live in areas
where the disease is endemic [3]. Schistosomiasis is an infection caused by trematodes of the
genus Schistosoma and occupies, after malaria, the second position in the world among para-
sitic infections [4,5]. This chronic disease is prevalent in tropical and subtropical regions,
mainly in regions that lack basic sanitation, allowing the proliferation of contaminating agents,
as well as the continuity of people being infected [2,3,6]. In addition, the absence of campaigns
that promote health education to the population, as well as the lack of dissemination of epide-
miological data, favor the continuity of the disease [6,7].
Tecnologico, Brasil. The funders had no role in
study design, data collection and analysis, decision
to publish or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
The current treatment for schistosomiasis is centered around praziquantel, an acylated
quinoline-pyrazine derivative, that is able to act against the main strains of Schistosoma man-
soni that infect humans and has been used for >30 years [8]. However, the exclusive use of pra-
ziquantel has been accompanied with reports in the literature that parasites isolated from
some patients have been resistant to pharmacological treatment [9–11]. Besides, praziquantel
has no effect on immature schistosomes and cannot prevent reinfection or alter the schisto-
some life cycle [12,13]. If it is considered that there is no effective alternative for the control of
schistosomiasis, it is evident that the risk of developing resistance to praziquantel will increase
in the coming decades, being a concern for the medical community. In view of this scenario,
research priorities for facing schistosomiasis include the development and testing of new
drugs, test combinations of praziquantel with new drugs as well as monitoring the spread of
praziquantel drug resistance [1].
In view of the need to obtain alternatives for the treatment of schistosomiasis and other
neglected diseases, efforts have been made within the medicinal chemistry, using various plan-
ning techniques to obtain substances with improved structural characteristics and with less
toxicity [14,15]. These attempts comprehend praziquantel chemical structure modification by
synthesis and evaluation of its analogues, rational design of new pharmacophores and discov-
ery of new active compounds from screening programs on a large scale [16].
A class of derivatives that has gained attention because of its promising experimental anti-
schistosomal activity is the one bearing the thiazole nucleus, which is effective against both
immature and adult S. mansoni worms [17]. The thiazole moiety plays an important role in
the medicinal chemistry field since it serves as a scaffold for new drug synthesis, being already
used as antimicrobial (sulfathiazole), anthelmintic and fungicide (thiabenzadole) and schisto-
somicide (niridazole) compounds [18–20]. Niridazole (Ambilhar1) started being used for
treatment in 1964, but patients had little tolerance to this drug with serious side effects due to
the presence of nitroaromatic chemical groups that act as parasitophores (their presence is
essential to kill the worm) and also cause damage to host DNA by formation of adducts that
induce mutagenesis [16]. However, advances in the development of medicinal chemistry tools
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
2 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
have recently allowed the synthesis of new thiazole derivatives with anti-schistosomal activity.
As an example, Santiago et al., 2014 [21] synthetized a set of molecules whose structures have a
hydrazine and/or thiazole nucleus as a common group, and different pharmacophores includ-
ing thiosemicarbazone, phthalyl thiosemicarbazone, phthalyl thiazole, and phthalyl thiazolidi-
none. Among them, the compounds comprised of thiazole and phthalimide were the ones that
exhibited the highest activity against worms, with a significant decline in motility, pairing and
oviposition, as well as a mortality rate of 100% after 144 h of treatment.
Recently, Reddy et al., 2018 [22] described the synthesis of a library of hydrazinyl-thiazoles
via a three-component reaction of various aldehydes/ketones with thiosemicarbazide and dif-
ferent phenacyl bromides, but the authors did not evaluate any biological potential of the
derivatives. Based on the potentially promising features of these new compounds, here we
selected eight aryl-thiazole derivatives and examined their efficacy in terms of (i) schistosome
survival, (ii) egg output (oviposition), (iii) motility, (iv) couples pairing, (v) ultrastructural
alterations in the tegument of S. mansoni as determined by scanning electron microscopy
(SEM), and (v) expression of S. mansoni developmental genes.
Materials and methods
Chemistry
Synthesis of the compounds bioassayed in this study was previously described [22–24]. Pro-
duction of aryl-thiazole derivatives was carried out at the Laboratory of Chemistry and Thera-
peutic Innovation, at the Federal University of Pernambuco. Synthesis was carried out in two
steps (Fig 1).
In the first step, the thiosemicarbazides (3.2 mmol) reacted in equimolar amounts with
,4-dimethoxy-benzaldehyde (right side route) or 3,4,5-trimethoxy-benzaldehyde (left side
2
route) through a condensation reaction in the presence of hydrochloric acid as the reaction
catalyst to obtain a thiosemicarbazone (TSC), which served as an intermediary for thiazole
synthesis following its acquisition. This second step was carried out in the presence of 2-
(2,4-dimethoxybenzylidene)thiosemicarbazone (0.62 mmol) or 2-(3,4,5-trimethoxybenzyli-
dene)thiosemicarbazone (0.55 mmol), 1.1 molar equivalent of different 2-chloro or 2-bromoa-
cetophenones (unsubstituted, 4-chloro-phenyl, 4-bromo-phenyl, 4-nitro-phenyl) under basic
conditions (4.0 molar equivalent of sodium acetate) and ethanol in reflux [25].
Reactions were monitored with analytical thin-layer chromatography in silica gel 60 F254
plates and visualized under UV light (254 nm). Melting points were determined on a Quimis
340 capillary melting point apparatus and were not corrected. IR spectra were measured on
Bruker IFS-66 IR spectrophotometer (Bruker, Germany) using KBr pellets. NMR spectra were
1
13
recorded on Bruker Avance (600 MHz for H and 150 MHz for C) instruments. HRMS were
performed on a MALDI-TOF Autoflex III (Bruker Daltonics, Billerica, MA, USA). The spec-
troscopic data of the synthesized compounds (NJ03 to NJ08, NJ11 and NJ12) are in accordance
with the structures proposed in Fig 1 and with the spectra published by Reddy et al., 2018 [22].
NJ03: (E)-4-(4-chlorophenyl)-2-((E)-(2,4-dimethoxybenzylidene)hydrazono)-2,3-dihy-
drothiazole. C H ClN O S. Yield: 71.20%. M.P.: 191-192ºC. Rf: 0.44 (7:3 n-hexane/ethyl
18
16
3 2
1
acetate). NMR H (600 MHz, DMSO) δ: 3.80 (s, 6H, OCH ); 6.60 (m, 2H, CH-Ar); 7.35 (s, 1H,
3
thiazole); 7.46 (d, 2H, CH-Ar, J = 12 Hz); 7.71 (d, 1H, CH-Ar, J = 6 Hz); 7.83 (d, 2H, CH-Ar,
13
J = 12 Hz); 8.38 (s, 1H, HC = N); 12.30 (s, 1H, NH). NMR C (DMSO, 150 MHz) δ: 55.94,
5
6.28, 104.85, 107.07, 115.38, 126.76, 127.93, 129.10, 129.99, 132.86, 139.66, 147.45, 159.19,
−1
+
162.68, 168.94. IR (KBr, cm ): 1396 (N = C-S), 1459 (C = N), 3317 (NH). HRMS m/z [M+H]
calcd for C H ClN O S: 374.069; found: 374.079.
18
16
3 2
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
3 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Fig 1. Route of synthesis to obtain the aryl-thiazole derivatives (NJ series). In the compounds, R was hydrogen,
4
-chloro, 4-bromo or 4-nitro. For 2,4-dimethoxy-aryl thiazole (right side route) R = Cl for NJ03; R = NO
2
for NJ06;
for
R = Br for NJ08 and R = H for NJ12. For 3,4,5-trimethoxy-aryl thiazole (left side route) R = Cl for NJ04; R = NO
NJ05; R = Br for NJ07 and R = H for NJ11.
2
https://doi.org/10.1371/journal.pone.0225425.g001
NJ04: (E)-4-(4-chlorophenyl)-2-((E)-(3,4,5-trimethoxybenzylidene)hydrazono)-
2
,3-dihydrothiazole. C H ClN O S. Yield: 61.80%. M.P.: 135-136ºC. Rf: 0.56 (7:3 n-hex-
1
1
9
18
3 3
ane/ethyl acetate). NMR H (600 MHz, DMSO) δ: 3.70 (s, 3H, OCH ); 3.87 (s, 6H, OCH );
3
3
6
.99 (s, 2H, CH-Ar); 7.38 (s, 1H, thiazole); 7.47 (d, 2H, CH-Ar, J = 6 Hz); 7.88 (d, 2H, CH-Ar,
13
J = 6 Hz); 7.97 (s, 1H, HC = N); 12.05 (s, 1H, NH). NMR C (DMSO, 150 MHz) δ: 56.34,
6
0.59, 104.05, 104.86, 127.67, 129.08, 130.40, 132.39, 134.06, 139.18, 141.76, 149.83, 153.67,
+
−1
168.87. IR (KBr, cm ): 1326 (N = C-S), 1411 (C = N), 3294 (NH). HRMS m/z [M+H] calcd
for C H ClN O S: 404.079; found: 404.081.
19
18
3 3
NJ05: (E)-4-(4-nitrophenyl)-2-((E)-(3,4,5-trimethoxybenzylidene)hydrazono)-2,3-dihy-
dro-thiazole. C H N O S. Yield: 55.20%. M.P.: 212-214ºC. Rf: 0.62 (6:4 n-hexane/ethyl
19
18 4 5
1
acetate). NMR H (600 MHz, DMSO) δ: 3.69 (s, 3H, OCH ); 3.86 (s, 6H, OCH ); 6.97 (s, 2H,
3
3
CH-Ar); 7.71 (s, 1H, thiazole); 8.00 (s, 1H, HC = N); 8.10 (d, 2H, CH-Ar, J = 6 Hz); 8.26 (d,
13
2
H, CH-Ar, J = 6 Hz); 12.34 (s, 1H, NH). NMR C (DMSO, 150 MHz) δ: 56.35, 60.59, 104.12,
1
09.00, 124.54, 126.79, 129.18, 130.28, 139.25, 141.07, 142.22, 146.66, 153.66, 165.09, 169.13. IR
+
−1
(KBr, cm ): 1345 (N = C-S), 1412 (C = N), 3305 (NH). HRMS m/z [M+H] calcd for
C H N O S: 415.103; found: 415.109.
19
18 4 5
NJ06: (E)-2-((E)-(2,4-dimethoxybenzylidene)hydrazono)-4-(4-nitrophenyl)-2,3-dihy-
drothiazole. C H N O S. Yield: 72.60%. M.P.: 218-220ºC. Rf: 0.68 (7:3 n-hexane/ethyl ace-
18
16 4 4
1
tate). NMR H (600 MHz, DMSO) δ: 3.81 (s, 6H, OCH ); 6.61 (m, 2H, CH-Ar); 7.64 (s, 1H,
3
thiazole); 7.70 (d, 1H, CH-Ar, J = 12 Hz); 8.08 (d, 2H, CH-Ar, J = 6 Hz); 8.24 (d, 2H, CH-Ar,
13
J = 12 Hz); 8.28 (s, 1H, HC = N); 12.09 (s, 1H, NH). NMR C (DMSO, 150 MHz) δ: 55.86,
5
6.20, 106.95, 108.56, 115.63, 124.49, 126.54, 126.76, 138.15, 141.16, 146.61, 148.88, 158.96,
−1
+
162.40, 169.23. IR (KBr, cm ): 1325 (N = C-S), 1413 (C = N), 3172 (NH). HRMS m/z [M+H]
calcd for C H N O S: 385.093; found: 386.100.
18
16 4 4
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
4 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
NJ07: (E)-4-(4-bromophenyl)-2-((E)-(3,4,5-trimethoxybenzylidene)hydrazono)-
2
,3-dihydrothiazole. C H BrN O S. Yield: 65.80%. M.P.: 159-161ºC. Rf: 0.45 (6:4 n-hex-
1
1
9
18
3 3
ane/ethyl acetate). NMR H (600 MHz, DMSO) δ: 3.70 (s, 3H, OCH ); 3.87 (s, 6H, OCH );
3
3
6
.98 (s, 2H, CH-Ar); 7.39 (s, 1H, thiazole); 7.61 (d, 2H, CH-Ar, J = 6 Hz); 7.81 (d, 2H, CH-Ar,
13
J = 6 Hz); 7.97 (s, 1H, HC = N); 12.22 (s, 1H, NH). NMR C (DMSO, 150 MHz) δ: 56.33,
5
6.52, 60.59, 104.05, 104.96, 120.97, 127.99, 130.39, 131.99, 134.38, 139.17, 141.79, 149.85,
−1
+
153.66, 168.88. IR (KBr, cm ): 1347 (N = C-S), 1409 (C = N), 3305 (NH). HRMS m/z [M+H]
calcd for C H BrN O S: 448.029; found: 448.032.
19
18
3 3
NJ08: (E)-4-(4-bromophenyl)-2-((E)-(2,4-dimethoxybenzylidene)hydrazono)-2,3-dihy-
drothiazole. C H BrN O S. Yield: 37.10%. M.P.: 173-174ºC. Rf: 0.57 (7:3 n-hexane/ethyl
18
16
3 2
1
acetate). NMR H (600 MHz, DMSO) δ: 3.80 (s, 6H, OCH ); 6.60 (m, 2H, CH-Ar); 7.36 (s, 1H,
3
thiazole); 7.60 (d, 2H, CH-Ar, J = 6 Hz); 7.71 (d, 1H, CH-Ar, J = 12 Hz); 7.77 (d, 2H, CH-Ar,
13
J = 12 Hz); 8.36 (s, 1H, HC = N); 12.20 (s, 1H, NH). NMR C (DMSO, 150 MHz) δ: 55.93,
5
6.27, 104.87, 107.05, 115.36, 126.71, 128.18, 130.26, 131.73, 132.00, 146.90, 159.13, 162.60,
−1
+
167.61, 168.94. IR (KBr, cm ): 1278 (N = C-S), 1421 (C = N), 3312 (NH). HRMS m/z [M+H]
calcd for C H BrN O S: 418.018; found: 418.030.
NJ11: (E)-4-phenyl-2-((E)-(3,4,5-trimethoxybenzylidene)hydrazono)-2,3-dihydrothia-
18
16
3 2
zole. C H N O S. Yield: 54.00%. M.P.: 193-195ºC. Rf: 0.52 (7:3 n-hexane/ethyl acetate).
19
19 3 3
1
NMR H (600 MHz, DMSO) δ: 3.70 (s, 3H, OCH ); 3.75 (s, 6H, OCH ); 6.99 (s, 2H, CH-Ar);
3
3
7
2
5
1
.31 (d, 2H, CH-Ar, J = 12 Hz); 7.40 (s, 1H, thiazole); 7.42 (d, 1H, CH-Ar, J = 12 Hz); 7.87 (d,
13
H, CH-Ar, J = 6 Hz);7.98 (s, 1H, HC = N); 12.22 (s, 1H, NH). NMR C (DMSO, 150 MHz) δ:
6.22, 56.34, 60.60, 104.03, 125.98, 127.99, 129.07, 130.46, 135.17, 139.14, 141.61, 150.98,
−1
+
53.67, 168.72. IR (KBr, cm ): 1324 (N = C-S), 1413 (C = N), 3176 (NH). HRMS m/z [M+H]
calcd for C H N O S: 370.118; found: 370.125.
19
19 3 3
NJ12: (E)-4-phenyl-2-((E)-(3,4,5-trimethoxybenzylidene)hydrazono)-2,3-dihydrothia-
zole. C H N O S. Yield: 61.40%. M.P.: 220-222ºC. Rf: 0.46 (7:3 n-hexane/ethyl acetate).
18
17 3 2
1
NMR H (600 MHz, DMSO) δ: 3.81 (s, 6H, OCH ); 6.62 (m, 2H, CH-Ar); 7.27 (s, 1H, thia-
3
zole); 7.29 (d, 1H, CH-Ar, J = 12 Hz); 7.40 (t, 2H, CH-Ar, J = 6 Hz); 7.73 (d, 1H, CH-Ar, J = 6
13
Hz); 7.86 (d, 2H, CH-Ar, J = 6 Hz); 8.28 (s, 1H, HC = N); 11.98 (s, 1H, NH). NMR C
(
DMSO, 150 MHz) δ: 55.88, 56.21, 103.65, 106.97, 115.85, 126.00, 126.51, 128.45, 129.03,
−1
1
35.28, 137.56, 151.01, 158.89, 162.29, 168.87. IR (KBr, cm ): 1331 (N = C-S), 1417 (C = N),
+
3
305 (NH). HRMS m/z [M+H] calcd for C H N O S: 340.108; found: 340.115.
18
17 3 2
Ethics statement
The experimental protocols were in accordance with the Ethical Principles in Animal Research
adopted by the Brazilian College of Animal Experimentation (COBEA) and the protocol/
experiments have been approved by the Ethics Committee for Animal Experimentation of
Institute Butantan (CEUA Nº 1777050816).
Maintenance of parasite life cycle
The BH strain of S. mansoni (Belo Horizonte, Brazil) was maintained in the intermediate snail
host Biomphalaria glabrata and the golden hamster (Mesocricetus auratus) was used as defini-
tive host. Female hamsters aged 3–4 weeks, freshly weaned, weighing 50–60 g, were housed in
cages (30x20x13cm) containing a sterile bed of wood shavings. A standard diet (Nuvilab CR-1
Irradiada, Quimtia S/A, Paran a´ , Brazil) and water were made available ad libitum. The room
temperature was kept at 22 ± 2˚C and a 12:12 hour light–dark cycle was maintained. Hamsters
were infected by exposure to a S. mansoni cercariae suspension containing approximately
200–250 cercariae using the ring technique [26]. After 49 days of infection, the S. mansoni
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
5 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
adult worms were recovered by perfusion of the hepatic portal system [27]. Cercariae were
released from infected snails and mechanically transformed to obtain schistosomula in vitro
[28].
Treatment of schistosomula and adult worms with NJ series compounds
Newly transformed schistosomula (NTS) were maintained for 2 h in M169 (Vitrocell) medium
supplemented with 2% fetal bovine serum (FBS) (Vitrocell), 1 μM serotonin, 0.5 μM
hypoxanthine,1 μM hydrocortisone, 0.2 μM triiodothyronine, penicillin/streptomycin,
amphotericin, gentamicin (Vitrocell) at 37˚C and 5% CO [28]. Only after 2 h incubation in
2
culture medium the NJ series treatment was initiated as follows: 6.25 μM, 12.5 μM, 25 μM or
5
0 μM compound, for 1–5 days. Paired adult worms freshly perfused from infected hamsters
see above) were maintained in culture in RPMI medium (Gibco) supplemented with 10%
fetal bovine serum (FBS) (Vitrocell), penicillin/streptomycin, amphotericin, gentamicin
Vitrocell) at 37˚C and 5% CO for 2 h prior to the beginning of treatment with NJ series com-
(
(
2
pound as follows: 12.5 μM, 25 μM or 50 μM compound, for 1–3 days of treatment. In all cases,
NJ series compounds were prepared from a stock solution of 20 mM in dimethyl sulfoxide
(DMSO), and the equivalent amount of DMSO was added to the control assays.
Motility assay of adult worms
To evaluate the general condition of adult worms, including motility and mortality rate an
inverted microscope was used. Parasites were observed after 1, 2 and 3 days of treatment with
different concentrations of NJ series compounds or vehicle DMSO at 0.1%. Motility and sur-
vival of worms were assessed according to the criteria scored in a viability scale of 0–3 [29].
The scoring system was as follows: 3, complete body movement; 1.5, partial body movement
or immobile but alive; and 0, dead. Treatment was considered lethal whenever no worm move-
ment was detected when observed for 2 min. Oviposition and pairing status were also observed
and eggs were counted.
Viability assay of schistosomula and adult worms
Viability of schistosomula and S. mansoni adult worms after treatment was determined by a
cytotoxicity assay based on the CellTiter-Glo1 Luminescent Cell Viability Assay kit (G7570,
Promega, Madison, Wisconsin, EUA) [30]. The assay determines the amount of ATP present
in freshly lysed adults or in intact schistosomula; the assay signals the presence of metabolically
active cells.
In addition, the viability of schistosomula was evaluated by the presence or absence of dead
parasites, through staining with propidium iodide (PI) [31]. Schistosomula were equally dis-
tributed in 96-well microtiter plates, incubated with different concentrations of NJ05 + NJ07
compounds indicated in the figure or the corresponding DMSO vehicle (control), and 2 μg/
mL propidium iodide (PI) (Sigma-Aldrich) were added at 2 days of drug exposure. The para-
sites were immediately observed with light microscopy at 10 x magnification using a Nikon
Eclipse fluorescence inverted microscope. Under fluorescence microscopy, schistosomula
death was scored by a red fluorescence signal (572 nm emission microscope filter) [31,32]. The
number of biological replicates that were assayed, as well as the number of parasites that were
counted per replicate, is stated in the legends to the figures.
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
6 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Cytotoxicity evaluation of NJ05, NJ07 or NJ05 + NJ07 in HEK293 and HES
human cell lines
HEK293 (Human Embryo Kidney- HEK-293 -ATCC CRL-1573) and HES (human endome-
trial epithelial cell line, kindly provided by Prof. Douglas Anthony Kniss—Ohio State Univer-
3
sity, USA) [33] cell cultures (5x10 cells/well) were incubated for two days with different
concentrations of NJ05, NJ07 or NJ05+NJ07 (3.125 μM—400 μM), and after treatment their
viability was measured by ATP quantitation with the CellTiter-Glo Luminescent Cell Viability
Assay (G7570, Promega, Madison, Wisconsin, EUA). The data was used for calculating the
EC50 with Origin software (OriginLab, Northampton, MA). All experiments were performed
with 3 biological replicates.
Scanning electron microscopy (SEM)
Adult worms collected by perfusion were immediately transferred to supplemented RPMI
medium; parasites were distributed in 6-well plates (adults: 10 paired worm couples per well)
with medium. The worms were kept in culture (oven at 37˚C and 5% CO ) for 2 h for adapta-
2
tion, and then NJ series compounds or the equivalent amount of 0.1% DMSO vehicle were
added.
Ultrastructural analysis was performed with scanning electron microscopy. Adult worms
incubated at different concentrations of NJ series compounds or with 0.1% DMSO vehicle for
1
and 2 days were fixed with modified Karnovsky reagent (1% paraformaldehyde, 2.5% glutar-
aldehyde, 1 mM calcium chloride in 0.1 M sodium cacodylate buffer, pH 7.4) and after the fix-
ing stage the material was washed with sodium cacodylate buffer (0.1 mol / L, pH 7.2) and
post-fixed with 1% osmium tetroxide (w / v) for 1 h.
Samples were dehydrated with increasing concentrations of ethanol and then dried with
liquid CO in a critical-point dryer machine (model Leica EM CPD030, Leica Microsystems,
2
Illinois, USA). Treated specimens were mounted on aluminum microscopy stubs and coated
with gold particles using an ion-sputtering apparatus (model Leica EM SCD050, Leica Micro-
systems, Illinois, USA) [34]. Specimens were then observed and photographed using an elec-
tron microscope (FEI QUANTA 250, Thermo Fisher Scientific, Oregon, USA).
RT-qPCR validation of S. mansoni developmental genes
For quantitative RT-PCR, complementary DNAs were obtained by reverse transcription (RT)
of 50 ng adult worms total RNA using SuperScript IV Reverse Transcriptase (Invitrogen) and
random hexamer primers in a 20 μL volume, according to the manufacturer’s recommenda-
tions. The resulting cDNA was diluted 8-fold in water and qPCR amplification was done with
2.5 μL of diluted cDNA in a total volume of 10 μL using SYBR Green Master Mix (Life Tech-
nologies) and specific primer pairs (S1 Table). Tested genes were described in previous publi-
cations from the literature [35–40] or selected here based on their predicted function; primers
were designed with the use of Primer3 online software. The Light cycle 480 II (Roche) qPCR
was used. Results were analyzed by comparative Ct method and the statistical significance was
calculated with the two-sided t-test.
To find adequate normalizer genes for qPCR, we looked for evidence of genes with non-
detectable changes in expression upon NJ series compounds treatment; ten genes were selected
based on literature reports [35–40] and tested by qPCR in the adult female worms for the lack
of effect of NJ series compounds on their levels of expression. The two least affected genes
were Mitochondrial 28s ribosomal protein s14 (Smp_090920) and PI3K regulatory subunit 4
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
7 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
(Smp_123610). In all cases, the geometric mean expression of these two genes was used as nor-
malizer for calculating the expression levels of genes of interest.
Results
Phenotypic effects of NJ series compounds on S. mansoni schistosomula
Eight different dimethoxy-aryl thiazole derivatives (see Fig 1) were tested for schistosomicidal
properties against schistosomula early forms of the parasite. For this, schistosomula were first
mechanically transformed from cercariae and were pre-incubated for 2 h in culture medium
prior to compound addition. After each compound was added, schistosomula viability was
evaluated every day for a period of five days by measuring the concentration of ATP in the
metabolically active cells of the parasite. Different concentrations of each compound from 6.25
to 50 μM were tested, and out of the eight compounds that were assayed (Fig 2A and Fig A in
S1 Text), two had a more prominent effect in reducing schistosomula viability, namely NJ05
and NJ07 (Fig 2A). These compounds decreased the parasites’ viability by approximately 40%
after five days of exposure (Fig 2A). In order to test for a combinatorial effect, the best two
compounds were assayed together. Within the first day of treatment with NJ05 + NJ07, across
all concentrations tested (12.5, 25 or 50 μM) there was a dose-dependent decrease of 60 to 80%
in parasite viability (Fig 2B), indicating a combinatorial effect between the two compounds.
The phenotype was more prominent after five days of treatment, with viability reduced to zero
(Fig 2B).
The effect on schistosomula viability over 5 days of exposure to each of the other six NJ
series compounds is shown at Fig A in S1 Text; a less marked 10 to 40% reduction in parasite
viability was observed.
Propidium iodide (PI) was used as an alternate method to quantitate viability of schistoso-
mula after a 2-days incubation in the presence of control vehicle (0.1% DMSO) or of 6.25 to
50 μM of the best two compounds together (NJ05 + NJ07) (Fig 2C and 2D). Under fluores-
cence microscopy, dead schistosomula were detected by a red fluorescence signal from PI (536
nm emission microscope filter) (Fig 2D, lower panels). Total number of schistosomula present
in the field was detected and counted under light optical microscopy at each NJ05 + NJ07 con-
centration (Fig 2D, upper panels), and the percentage viability was computed and plotted as
shown in Fig 2C; mortality was 100% with 25 or 50 μM NJ05 + NJ07. Incubation with control
vehicle (0.1% DMSO) for 2 days showed no reduction in parasite viability (Fig 2B and 2D, first
upper and lower panels).
Effects of NJ series compounds on S. mansoni adult worms’ viability and
motility
In order to evaluate the schistosomicidal activity of all eight compounds on adult worms the
oviposition, male-female pairing status, worms’ viability, motility, and alterations in the tegu-
ment were measured. Compounds were tested at a concentration range of 12.5 to 50 μM and
observed every day for a period of 3 days.
Again, compounds NJ05, NJ07 or NJ05 + NJ07 exhibited the highest schistosomicidal activ-
ities among the eight tested, showing a concentration-dependent significant decrease in viabil-
ity of the adult worms, as evaluated by ATP quantitation (Fig 3A–3C). Compound NJ05 was
more effective than NJ07, and viability after three days was reduced to 25% in parasites treated
with 50 μM NJ05 (Fig 3A), compared with a viability reduction to 60% with 50 μM NJ07 (Fig
3B). No combinatorial effect was detected when the two compounds were tested together
(NJ05 + NJ07), as the viability was reduced to approximately 25% after three days of exposure
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
8 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Fig 2. Effect of NJ05, NJ07 or NJ05 + NJ07 on schistosomula viability. (A and B) ATP quantitation using a luminescent assay to assess schistosomula viability
under NJ series compounds exposure. Schistosomula (100-120/well) were incubated with the indicated concentrations of NJ05, NJ07, NJ05 + NJ07 or with vehicle
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
9 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
(
0.1% DMSO) for up to 5 days. Viability was expressed as % luminescence values relative to the control (DMSO). Mean ± SEM from three biological replicate
�
��
���
experiments are shown. The two-way ANOVA test was used to calculate the statistical significance ( p < 0.05; p < 0.01; p < 0.001). For clarity purposes, we
show only the highest p-value obtained from the two-way ANOVA test for each time point on all different concentrations tested. (C) Quantitation of schistosomula
viability using propidium iodide staining; schistosomula were treated for two days with NJ05 + NJ07 at the different concentrations indicated. Percentage of viable
schistosomula (non-stained with propidium iodide) is shown. For each condition tested, about 400 schistosomula were used, divided into four biological replicates.
Mean ± SEM from four replicate experiments are shown. (D) Schistosomula treated with the indicated concentrations of NJ05 + NJ07 or with vehicle (0.1% DMSO)
for 2 days were visualized by staining with propidium iodide (marker of dead cells; 572 nm emission filter microscope). For each concentration (indicated at the
top), the upper panel shows a light microscopy image and the bottom panel shows the image of the same field with differential fluorescence detection of PI-positive
parasites. Bar = 100 μm.
https://doi.org/10.1371/journal.pone.0225425.g002
to 50 μM NJ05 + NJ07 (Fig 3C), similar to the reduction caused by NJ05 only. The effect of
other tested compounds is shown at Fig B in S1 Text; after three days of treatment with com-
pounds NJ03, NJ04 or NJ08 (at 50 μM concentration), a reduction in viability to only 75% was
observed.
S. mansoni adult worms exhibited a larger decrease in motility when exposed to NJ05 or
NJ05 + NJ07, compared with NJ07 treatment alone. This phenotype was dependent upon con-
centration and incubation time (Fig 3D–3F). After three days with the lowest concentration
tested (12.5 μM), NJ05 or NJ05 + NJ07 decreased the motility to 40–50% compared with con-
trols (Fig 3D and 3F), while NJ07 treatment at the same concentration led to a reduction of
only 15–20% in motility (Fig 3E). Impairment of the peristaltic movement and reduced ability
of the suckers to adhere to the bottom of the culture plates were observed. Among the other
compounds of the NJ series tested we can highlight the 50% decrease in motility of adult
worms exposed to 50 μM NJ03 or NJ08 after three days of exposure (Fig C in S1 Text).
Effects of NJ series compounds on S. mansoni adult worm couples pairing
and female oviposition
Compound NJ05 showed a more pronounced effect than NJ07 on worm couples pairing (Fig
4A and 4B). Thus, couples exposed for one day to 25 μM or 50 μM NJ05 already exhibited no
pairing (Fig 4A), whereas there was no couple pairing reduction at day one with 25 μM NJ07,
and with 50 μM NJ07, pairing was reduced to approximately 60% compared with control (Fig
4B). Combination of NJ05 + NJ07 was not effective in enhancing couples unpairing (Fig 4C)
when compared with NJ05 alone. Among other NJ series compounds (see Fig D in S1 Text), it
can be highlighted the unpairing of approximately 75% - 90% of adult worm couples after
three days exposure to 50 μM NJ03, NJ04, NJ08 or NJ11.
In addition, oviposition was extremely affected by treatment with the NJ series compounds,
especially NJ05, NJ07 or NJ05 + NJ07 (Fig 4D–4F). Of note, reduction in oviposition was inde-
pendent from couple unpairing. Thus, at concentrations of 25 μM or 50 μM, oviposition
reached almost zero with NJ05, NJ07 or NJ05 + NJ07 already at day one (Fig 4D–4F), even
when unpairing was incomplete or not present such as with NJ07 (compare Fig 4B and 4E).
Results for oviposition reduction of the other tested compounds are described at Fig E in S1
Text; little effect was observed in oviposition with these other compounds.
EC50 assay of NJ05, NJ07 or NJ05 + NJ07 in HEK293 and HES human cell
lines
Toxicity of the compounds was evaluated by ATP quantitation on human HEK293 embryonic
kidney cell line and human HES endometrial epithelial cell line in culture, after exposure for
two days to 3.125–200 μM NJ05, NJ07 or NJ05 + NJ07. The concentrations of NJ05, NJ07 or
NJ05 + NJ07 that caused a 50% reduction in viability (EC50) of HEK293 cells were 46.64 μM,
92.35 μM, and 18.42 μM, respectively (Fig F in S1 Text). And for HES cell line the EC50 with
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
10 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Fig 3. In vitro effects of NJ05, NJ07 or NJ05 + NJ07 on the viability and motility of Schistosoma mansoni adult worms. (A—C) Viability was
estimated by the total amount of ATP available in the parasites, using a luminescent assay. Pairs of adult worms were treated for 2 days with NJ05, NJ07
or NJ05 + NJ07 at the different concentrations indicated or with vehicle (0.1% DMSO). Viability was expressed as percentage luminescence values
relative to the control (DMSO). Mean ± SEM from three replicate experiments are shown, each with 10 worm pairs. (D—F) Percentage of relative
motility of adult worms treated with different concentrations of NJ05, NJ07 or NJ05 + NJ07 and controls (0.1% DMSO) at different times of exposure
�
��
���
from 1 to 3 days. Mean ± SEM of three experiments, each with 10 worm pairs. p < 0.05, p < 0.01 and
p < 0.001 compared with controls. For
clarity purposes, we show only the highest p-value obtained from the two-way ANOVA test for each time point on all different concentrations tested.
https://doi.org/10.1371/journal.pone.0225425.g003
NJ05, NJ07 or NJ05 + NJ07 were 133.53 μM, 145.20 μM and 29.59 μM, respectively (Fig F in
S1 Text).
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
11 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Fig 4. In vitro effects of NJ05, NJ07 or NJ05 + NJ07 on pairing and oviposition of Schistosoma mansoni adult worms. (A-C) We monitored the pairing of
control couples and of couples treated with different concentrations of NJ05, NJ07 or NJ05 + NJ07 at different times of exposure from 1 to 3 days. Mean ± SEM of
three experiments are shown, each with 10 worm pairs. (D-F) Number of eggs released by females incubated with NJ05, NJ07 or NJ05 + NJ07 at different
�
��
���
concentrations or with vehicle (0.1% DMSO) at different times of exposure from 1 to 3 days. p < 0.05, p < 0.01 and p < 0.001. For clarity purposes, we
show only the highest p-value obtained from the two-way ANOVA test for each time point on all different concentrations tested.
https://doi.org/10.1371/journal.pone.0225425.g004
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
12 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Scanning electron microscopy of treated adult worms
Through scanning electron microscopy (SEM) it was possible to detect phenotypic alterations
between control and treated adult worms. Control adult male schistosomes that were not
exposed to any drugs are depicted in Fig 5 (panels 1–4) and Fig 6 (panels 1–4) and showed a
normal topography of the surface membrane of anterior and dorsal regions, respectively. Oral
and ventral suckers could be clearly visualized (Fig 5, panels 2–4). In the anterior portion of
the body, the gynecophoral canal, a longitudinal fold of the middle and posterior body that
houses the female for the purpose of mating and reproduction, could be identified (Fig 5,
panel 2). In Fig 6, panels 1 to 4, the medial and posterior parts of schistosomes are shown,
respectively. In these regions, a large number of tubercles with typical spines and ciliated papil-
lae was observed (Fig 6, panels 2 and 3).
SEM revealed detailed surface membrane ultrastructural damage on the anterior (Fig 5)
and dorsal (Fig 6) regions of adult male worms caused by in vitro exposure for 2 days to 25 μM
NJ05 (Figs 5 and 6, panels 5–8) or NJ07 (Figs 5 and 6, panels 9–12) compared with controls
(0.1% DMSO) (Figs 5, and 6, panels 1–4). Thus, incubation of adult male S. mansoni worms
with NJ05 resulted in severe tegument destruction of the anterior region (Fig 5, panels 5–8). In
Fig 5. Micrographs showing alterations on the ultrastructure of the anterior region of Schistosoma mansoni adult male worms exposed to NJ05 or NJ07.
Scanning electron microscopy of worms exposed for 2 days to 25 μM NJ05 (panels 5–8), 25 μM NJ07 (panels 9–12) or vehicle (0.1% DMSO) (panels 1–4). Note
that the size scale bar is shown within the black thin line below each image; panels 1 and 2: Control worms (Bar = 500 μm; 100 μm) presented the fully paired
couple; panels 3 and 4: Anterior region of control male presented normal oral and ventral suckers tegument (Bar = 50 μm; 30 μm); panels 5 and 6: Anterior
region of adult male worm treated with 25 μM NJ05 (Bar = 500 μm; 100 μm); panels 7 and 8: Male oral and ventral suckers presented tegument peeling
(Bar = 50 μm); panels 9 and 10: Anterior region of male adult worm treated with 25 μM NJ07 (Bar = 500 μm; 100 μm); panels 11 and 12: Male oral and ventral
suckers presented tegument without structural alterations (Bar = 50 μm). f: female; os: oral sucker; vs: ventral sucker; gc: gynecophoral canal; la: lesion area; cp:
ciliated papillae.
https://doi.org/10.1371/journal.pone.0225425.g005
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
13 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Fig 6. Scanning electron micrographs of dorsal and posterior regions of Schistosoma mansoni adult male worm
exposed to NJ05 or NJ07. Worms were exposed for 2 days to 25 μM NJ05 (panels 5–8), 25 μM NJ07 (panels 9–12) or
vehicle (0.1% DMSO) (panels 1–4). Panels 1 to 4: Medial (panels 1–3) and posterior (panel 4) regions of control male
worm presented normal tegument (Bar = 50 μm; 20 μm; 5 μm; 50 μm). Note that the size scale bar is shown within the
black thin line below each image. Panels 5 to 7: Enlarged view of dorsal region of adult male worm treated with NJ05
showing tegument lesions and loss of tubercles (Bar = 50 μm; 20 μm; 5 μm; 50 μm); panel 8: Posterior region of male
adult worm treated with NJ05 showing lesion areas (Bar = 50 μm); panels 9 to 11: Dorsal region of male adult worm
treated with NJ07 showed bubbles throughout (Bar = 30 μm; 20 μm; 5 μm; 50 μm); panel 12: Posterior region of male
adult worm treated with NJ07 (Bar = 50 μm). cp: ciliated papillae; b: blebs; tb: tubercles; la: lesion area.
https://doi.org/10.1371/journal.pone.0225425.g006
the ventral anterior region, focal lesions were observed in the oral and ventral suckers (Fig 5,
panels 7 and 8). In the anterior portion of the body exposed to NJ07 the tegument showed no
alterations (Fig 5, panels 9–12), and exhibited numerous ciliated papillae similar to the control
(Fig 5, panels 1–4).
Severe damage to the dorsal surface of adult male schistosomes was induced by incubation
for 2 days with NJ05 (Fig 6, panels 5–8) or NJ07 (Fig 6, panels 9–12). After NJ05 treatment,
deterioration of the dorsal tegument was observed at higher magnification (Fig 6, panels 5–7),
with the presence of lesion areas and loss of numerous tubercles and spines that covered the
whole body of the parasite. In the posterior region, focal lesions along the body became evident
(Fig 6, panel 8). Countless bubbles and loss of ciliated papillae were observed in the dorsal
region of male worm exposed to NJ07 (Fig 6, panels 9–11); tegument at the male worm poste-
rior region had no structural alterations (Fig 6, panel 12). Similar structural changes were
already detected in adult male worms exposed for only 24 h to NJ05 or NJ07, with a more pro-
nounced effect of NJ05 (Fig G in S1 Text).
Control females incubated with vehicle (0.1% DMSO) showed a normal surface (Fig 7, pan-
els 1–4). In females treated with 25 μM NJ05 for 2 days, severe damage to the dorsal tegument
was visualized (Fig 7, panels 6–8), and exhibited extensive sloughing that exposed subtegu-
mental tissues. Presence of blisters could be seen throughout the extension of the dorsal region
of female exposed to 25 μM NJ07 for 2 days (Fig 7, panels 10–12).
Assessment by quantitative PCR of the expression of genes involved with
vitellaria and female reproduction
Since a strong reduction on oviposition was observed after treatment with NJ series com-
pounds, a set of six genes that are involved in egg formation and participate in cell
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
14 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Fig 7. Damaged dorsal surface of S. mansoni adult female worms exposed to NJ05 or NJ07. Female worms were exposed for 2 days to 25 μM NJ05 (panels
5–8), 25 μM NJ07 (panels 9–12) or to vehicle (0.1% DMSO) (panels 1–4) and were observed by scanning electron microscopy; note that the size scale bar is shown
within the black thin line below each image. panel 1: Low magnification image of female control worm (Bar = 500 μm). panels 2 to 4: Images of female control
worms dorsal region, with normal structural appearance (Bar = 40 μm; 10 μm and 4 μm); panel 5: Low magnification image of female worm exposed to NJ05
(Bar = 500 μm); panels 6 to 8: Middle dorsal region of female presented apparent surface damage with peeling of the tegument membrane (Bar = 50 μm; 10 μm
and 5 μm); panel 9: Low magnification image of female worm exposed to NJ07 (Bar = 500 μm); panels 10 to 12: Dorsal region of female worm presented bubbles
along the tegument (Bar = 30 μm; 10 μm and 4 μm). p: peeling; la: lesion area; b: blebs.
https://doi.org/10.1371/journal.pone.0225425.g007
differentiation was selected for assessment of their possible change in expression by RT-qPCR.
Tested genes involved in egg biosynthesis were all confirmed by RT-qPCR as downregulated
in females treated with 25 μM NJ05 for 2 days (Fig 8), with a significant reduction in expres-
sion of p14, Tyrosinase 2, p48 and fs800. Two other genes tested by qPCR showed non-statisti-
cally-significant changes; they were the Egg Shell Protein (ESP) gene, and the Nanos 2 gene,
which is involved in vitelline cell differentiation [41]. It is evident that NJ05 had a direct effect
on the expression level of selected genes that are involved with eggshell formation and egg
development in S. mansoni females [41].
The effect of NJ07 or NJ05 + NJ07 on the expression of the same set of six genes was also
tested; worms were treated for 2 days with 25 μM NJ07 or NJ05 + NJ07; the only gene detected
by RT-qPCR as significantly 2.8–2.9 X downregulated in females under both treatments was
Nanos 2, a gene related to cell differentiation (Fig H in S1 Text). Although oviposition was
impaired in both treatment conditions (see Fig 4E and 4F), there was no significant change in
expression caused by both treatments among the five tested genes related to eggshell formation
and egg development (Fig H in S1 Text), indicating that other genes may have been affected by
the treatment.
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
15 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Fig 8. Vitellaria and female reproduction gene expression inhibition in adult females upon NJ05 treatment. Adult
couples were treated with NJ05 (25 μM) or with vehicle DMSO (0.1%) for 2 days. The parasites were stored in
RNAlater (Ambion) for further processing. All parasite couples were separated and only the females had their RNA
extracted followed by cDNA synthesis. The genes measured by RT-qPCR were Smp_131110 (p14), Smp_000430 (Egg
Shell Protein (ESP)), Smp_013540 (Tyrosinase 2 (Tyr 2)), Smp_014610 (p48), Smp_000290 (fs800), Smp_055740
(Nanos 2). The geometric mean from two reference genes (Smp_090920 and Smp_123610) was used for normalization
with the DCT method. The plotted data is retrieved from DDCT analyses in which the DMSO-treated sample is the
control. Significant fold-change in gene expression between DMSO and NJ05 treatment is shown by the numbers
inside the brackets. Mean ± SEM of four replicates is shown. Student unpaired parametric two-sided t-test was used,
�
��
and statistically significant differences are represented by the asterisks. p ꢀ 0.05; p ꢀ 0.01.
https://doi.org/10.1371/journal.pone.0225425.g008
Discussion
Chemotherapy is the only immediate recourse for minimizing the prevalence of schistosomia-
sis, and currently it involves predominately the administration of a single drug, praziquantel
(PZQ). There is an important limitation of the therapeutic profile of PZQ, as it lacks activity
against larval developing stages of the parasite; therefore, retreatment is necessary to kill those
parasites that have since matured [21,42]. The present study was performed to evaluate the in
vitro schistosomicidal effect of the aryl-thiazole derivatives both on adults and on the larval
developing stages of the parasite. The following schistosomicidal parameters were analyzed:
viability, motility, oviposition, mortality and morphological changes, which are indicators
commonly used for evaluating the schistosomicidal effect of new chemical entities [43,44]. In
light of the parasite biology and according to the evaluation of these parameters, schistosomici-
dal activity can be effective essentially in three different ways: causing schistosomula death,
thus preventing host infection, inhibiting oviposition that could lead to a decrease in the path-
ological phenotype of schistosomiasis (hepato- and splenomegaly), and causing adult worm’s
death [44,45]. All three of the above schistosomicidal effects were present in our in vitro assays
with NJ compounds, suggesting that further exploration of this class of aryl-thiazole derivatives
is warranted.
The aryl-thiazole compounds evaluated in this study are differentiated, in principle, by the
substitution pattern of the phenyl ring directly attached to the hydrazine portion
(2,4-dimethoxy-phenyl and 3,4,5-trimethoxy-phenyl). Trimethoxylated derivatives (NJ04,
NJ05, NJ07 and NJ11) showed a better profile in reducing the viability of S. mansoni schistoso-
mula and adult worms compared with the dimethoxylated ones (NJ03, NJ06, NJ08 and
NJ012). One important chemical property of methoxy substituent is that its oxygen atom is an
acceptor of proton for different types of hydrogen-bonds [46] favoring the biological activity
of new compounds by improving the target recognition [47]. Besides, trimethoxy-substitution
increases the electronic density, and this could also be related to the higher schistosomicidal
activity of this class compared with the dimethoxylated ones. The results corroborate with
studies involving other parasites such as Plasmodium falciparum [48], Leishmania braziliensis
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
16 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
[49] and Trypanosoma cruzi [50], evidencing the importance of methoxy group trisubstituted
aromatic nuclei for antiparasitic activity.
Additionally, the two aryl-thiazole series are discriminated by the presence of different sub-
stituents of the phenyl ring attached to the thiazole nucleus (hydrogen, 4-chloro, 4-bromo,
4
-nitro). The best compounds evaluated in this study have 4-nitro (NJ05) and 4-bromo
NJ07). Notably, such substitutions reflect an increase in antiparasitic activity as described in
the literature; Papadopoulou et al., 2016 [51] described the antitrypanosomal activity of
-nitro-2-aminothiazole and demonstrated activity against T. cruzi amastigotes at nanomolar
(
5
concentrations and was about 4-fold more potent than BNZ (benznidazole-reference drug).
Generally, the biological activity of nitro compounds involves the biotransformation of the
nitro group, releasing intermediates that disrupt the redox process. Some of those intermedi-
ates can attack enzymes, membranes and DNA, providing the basis for their mode of action,
including those reported against parasites [52]. NJ compounds might have caused oxidative
stress and the consequent biological activity observed here.
The insertion of halogen atoms, in turn, on the compound structure in the discovery phase
of new drugs can lead to increased potency and selectivity of the pharmacological target by
affecting the pKa, modulating the conformation, increasing hydrophobic interactions between
the ligand and the target, increasing lipophilicity and favoring permeation in biological mem-
branes [53,54]. The increase in cellular permeability of the parasite membrane is an important
feature for the action of a target drug; for example, PZQ is supposed to act on the voltage-
gated calcium channels of schistosomes [55], but has also been shown to alter membrane fluid-
ity in model membranes [56] and in the S. mansoni tegument [57], thus possibly increasing
calcium permeability. The effects of para-substituents on biological activity can be explained
by the hydrophobicity (π) and electronic effects (σ) as stated by Craig, 1971 [58]. Both NO2
and Bromo substituents present positive electronic (+ σ) and lipophilic (+ π) effects. This
means inferior availability of free electron pairs, which could promote membrane permeation.
The phenotypic effects observed over the course of NJ05 treatment on S. mansoni couples
included reduction in motility, impairment of peristaltic movement and of the ability of their
suction suckers to adhere to the bottom of the culture plates, thus generating weak contrac-
tions and subsequent paralysis. This may be a consequence of the perturbation in the influx of
extracellular calcium, which in eukaryotic cells is a signal for motor events, besides playing an
important role in the promotion of apoptosis [59–61]. Further studies are necessary to explore
other structural aspects of these compounds besides their possible lipophilicity contribution to
membrane permeabilization.
Changes in the general conditions of worms, including adult worms’ motility and tegument
damage visualized through high resolution scanning electron microscopy were observed after
two days treatment with 25 μM NJ05 + NJ07. Motility assay and cytotoxicity evaluation by
ATP quantification revealed an increase in the number of dead parasites that was concentra-
tion and time dependent following NJ05 + NJ07 treatment. Maximum death of adult worms
occurred after three days of treatment at concentrations of 25 or 50 μM NJ05 + NJ07. Note-
worthy, in schistosomula 100% death happened in the first two days (25 or 50 μM NJ05
+
NJ07). The larvae presented lack of movement, granularity and shape alterations, showing
that NJ05 + NJ07 combination was effective against younger forms of the parasite. This is of
great importance, since the drugs of choice for treatment of schistosomiasis act on adult
worms, having a small action on schistosomula [62].
Detailed microscopic observation showed that NJ05 or NJ07 were capable, separately, of
inducing morphological alterations in the outer membrane of all adult worms tested in this
work. We found extensive damage to the tegument in both male and female worms after 2
days of exposure to NJ05 or NJ07. Male adult worms of S. mansoni treated with NJ05 showed
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
17 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
lesions of tegument and loss of tubercles; the females, in turn, demonstrated severe damage on
the tegument surface with the presence of blisters and large peeling of the tegument. Upon
NJ07 in vitro treatment the dorsal region of male and female adult worms showed bubbles in
all their extension. Alterations in the surface ultrastructure of schistosome worms have been
investigated by a number of authors in order to evaluate anti-schistosomal drugs [63–68].
Here, the alterations caused by NJ05 or NJ07 indicate that trimethoxy substituent and the pres-
ence of NO and Br substituents favored damage on male and female adult worms.
2
The compounds tested here appeared to influence adult females’ oviposition, mainly NJ05
and NJ05 + NJ07, since no eggs at all were found in the culture medium after treatment under
these two conditions. Eggs obtained from couples treated with NJ07 were smaller than control
eggs and probably not viable due to their lack of germinal disks formation. In females treated
with NJ05, the expression of genes related to egg biosynthesis including tyrosinase (SmTyr2)
[69], and eggshell precursors such as p14 [70] and p48 [71] were found to be decreased in rela-
tion to the control.
Also, genes related to cell differentiation and development of the germinative line of meta-
zoans such as Nanos 2 were found to have decreased expression in relation to the control in
adult females treated with NJ05, NJ07 or NJ05 + NJ07. On platyhelminths, Nanos 2 is generally
found to be expressed in the anterior portion of the ovary [41], where the oogonias are located
[72], and it plays an essential role in the proper development, regeneration and maintenance
of germ cells in several organisms [73–75].
Overall, the results indicate that thiazoles, especially those trimethoxylated derivatives are
antiparasitic agents. These compounds showed substantial schistosomicidal properties against
schistosomula and adult S. mansoni worms, with a significant reduction in viability, motility,
pairing, survival rate, oviposition, severe alterations in the tegument and mortality of worms,
and further biological studies are warranted to clarify the mechanisms of schistosomicidal
action. It is important to emphasize that NJ05 + NJ07 had an intense activity against the young
forms of S. mansoni in vitro, a characteristic not encountered in the drugs of choice for treat-
ment of schistosomiasis such as PZQ and oxamniquine [8,76].
Cytotoxic effect for HEK293 human embryonic kidney cell line was higher (EC50 of 46.64,
92.35 and 18.42 μM for NJ05, NJ07 and NJ05+NJ07, respectively) than the cytotoxic effect for
HES somatic epithelial cell line (EC50 of 133.53, 145.20 and 29.59 μM for NJ05, NJ07 and
NJ05+NJ07, respectively) suggesting that these compounds may be more effective in diminish-
ing viability of embryonic cells that undergo proliferation than in somatic cells. Systematically,
the combination between NJ05+NJ07 showed a cytotoxic effect higher than the compounds
separately, but it is worth mentioning that the best compound in reducing viability of both
schistosomula and adult worms was NJ05. Given that the EC50 for NJ05 in the HEK293
human cell line is in the medium micromolar range (46.64 μM), and in the HES human cell
line the EC50 is in the high micromolar range (133.53 μM), this compound could be used as
an aryl-thiazole prototype for the development of new schistosomicidal compounds in the
future.
Supporting information
S1 Text. Supplementary Figs A to H. Fig A, ATP quantitation using a luminescent assay to
assess schistosomula survival under NJ series compounds exposure; Fig B, Effect of NJ series
compounds on the viability of S. mansoni adult worms; Fig C, Effect of NJ series compounds
on the motility of S. mansoni adult worms; Fig D, In vitro effect of NJ series compounds on
pairing of S. mansoni adult worm couples; Fig E, In vitro effects of NJ series compounds on
oviposition of S. mansoni adult worms; Fig F, Cytotoxicity evaluation of exposure of two
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
18 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
different human cell lines to NJ series compounds; Fig G, Structural damage was observed by
scanning electron microscopy of male worms already at 24 h exposure to NJ05 or NJ07; Fig H,
Vitellaria and female reproduction gene expression in adult females upon NJ07 or NJ05+NJ07
treatment.
(
PDF)
S1 Table. List of primers used in qPCR.
XLSX)
(
Acknowledgments
We thank Beatriz Mauricio and Dr. Carlos Jared, Instituto Butantan, Sao Paulo, for access to
the scanning electron microscopy facilities in their laboratories. We acknowledge Dr. Eliana
Nakano and Patricia Aoki Miyasato, Instituto Butantan, Sao Paulo, and Dr. Pedro Luiz Silva
Pinto, Instituto Adolfo Lutz, Sao Paulo, for maintaining the parasite life cycle.
Author Contributions
Conceptualization: Adriana S. A. Pereira, Sergio Verjovski-Almeida.
Data curation: Adriana S. A. Pereira, Gilbert O. Silveira, Sinara M. V. Almeida, Jamerson F.
Oliveira.
Formal analysis: Adriana S. A. Pereira, Gilbert O. Silveira, Sinara M. V. Almeida, Jamerson F.
Oliveira, Maria C. A. Lima.
Funding acquisition: Maria C. A. Lima, Sergio Verjovski-Almeida.
Investigation: Adriana S. A. Pereira, Murilo S. Amaral.
Methodology: Adriana S. A. Pereira, Gilbert O. Silveira, Murilo S. Amaral.
Project administration: Sergio Verjovski-Almeida.
Resources: Sergio Verjovski-Almeida.
Supervision: Sergio Verjovski-Almeida.
Visualization: Gilbert O. Silveira.
Writing – original draft: Adriana S. A. Pereira, Sergio Verjovski-Almeida.
Writing – review & editing: Adriana S. A. Pereira, Gilbert O. Silveira, Sinara M. V. Almeida,
Sergio Verjovski-Almeida.
References
1.
McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev
Dis Prim. 2018/08/11. 2018; 4: 13. https://doi.org/10.1038/s41572-018-0013-8 PMID: 30093684
2.
Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet. 2006/09/26. 2006; 368:
1
1
106–1118. S0140-6736(06)69440-3 [pii] https://doi.org/10.1016/S0140-6736(06)69440-3 PMID:
6997665
3
.
.
WHO. Schistosomiasis. Fact sheet accessed 20 Feb 2019. 2018;
4
Keiser J, Chollet J, Xiao SH, Mei JY, Jiao PY, Utzinger J, et al. Mefloquine—an aminoalcohol with prom-
ising antischistosomal properties in mice. PLoS Negl Trop Dis. 2009/01/07. 2009; 3: e350. https://doi.
org/10.1371/journal.pntd.0000350 PMID: 19125172
5.
Lescano SZ, Chieffi PP, Canhassi RR, Boulos M, Amato Neto V. [Antischistosomal activity of arte-
mether in experimental Schistosomiasis mansoni]. Rev Saude Publica. 2004/02/14. 2004; 38: 71–75.
https://doi.org/10.1590/s0034-89102004000100010 [pii] PMID: 14963544
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
19 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
6.
Kuntz AN, Davioud-Charvet E, Sayed AA, Califf LL, Dessolin J, Arner ES, et al. Thioredoxin glutathione
reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med.
2007/06/21. 2007; 4: e206. 06-PLME-RA-0587 [pii] https://doi.org/10.1371/journal.pmed.0040206
PMID: 17579510
7
.
.
Katz N, Coelho PM. Clinical therapy of schistosomiasis mansoni: the Brazilian contribution. Acta Trop.
2008/07/12. 2008; 108: 72–78. https://doi.org/10.1016/j.actatropica.2008.05.006 [pii] PMID: 18617155
8
Siqueira LD, Fontes DAF, Aguilera CSB, Timoteo TRR, Angelos MA, Silva LCPBB, et al. Schistosomia-
sis: Drugs used and treatment strategies. Acta Trop. 2017; 176: 179–187. https://doi.org/10.1016/j.
actatropica.2017.08.002 PMID: 28803725
9.
Pica-Mattoccia L, Doenhoff MJ, Valle C, Basso A, Troiani AR, Liberti P, et al. Genetic analysis of
decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni. Acta Trop. 2009/05/
12. 2009; 111: 82–85. https://doi.org/10.1016/j.actatropica.2009.01.012 [pii] PMID: 19426668
1
1
1
1
1
0. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB, et al. Reduced suscep-
tibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl
Trop Dis. 2009; https://doi.org/10.1371/journal.pntd.0000504 PMID: 19688043
1. Doenhoff MJ, Cioli D, Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives
for schistosomiasis. Curr Opin Infect Dis. 2008/11/04. 2008; 21: 659–667. https://doi.org/10.1097/QCO.
0b013e328318978f [pii] PMID: 18978535
2. Cioli D, Pica-Mattoccia L, Basso A, Guidi A. Schistosomiasis control: praziquantel forever? Mol Bio-
chem Parasitol. 2014/06/24. 2014; 195: 23–29. https://doi.org/10.1016/j.molbiopara.2014.06.002
PMID: 24955523
3. Ross AGP, Olveda RM, Li YS. An audacious goal: the elimination of schistosomiasis in our lifetime
through mass drug administration. Lancet. 2015; 385: 2220–2221. https://doi.org/10.1016/S0140-6736
(14)61417-3 PMID: 25467574
4. Barreiro EJ, Fraga CAM, Miranda ALP, Rodrigues CR. A qu ´ı mica medicinal de N-acilidrazonas: novos
compostos-prot o´ tipos de f a´ rmacos analg e´ sicos, antiinflamat o´ rios e anti-tromb o´ ticos. Qu ´ı m Nov. 2002;
25: 129–148. http://dx.doi.org/10.1590/S0100-40422002000100022
15. Manssour Fraga CA, Barreiro EJ. New Insights for Multifactorial Disease Therapy: The Challenge of the
Symbiotic Drugs. Curr Drug ther. 2008; 3: 1–13. https://doi.org/10.2174/157488508783331225
16. da Silva VBR, Campos B, de Oliveira JF, Decout JL, do Carmo Alves de Lima M. Medicinal chemistry of
antischistosomal drugs: Praziquantel and oxamniquine. Bioorg Med Chem. 2017/05/13. 2017; 25:
3259–3277. https://doi.org/10.1016/j.bmc.2017.04.031 PMID: 28495384
1
7. de Oliveira SA, de Oliveira Barbosa M, Filho C, Oliveira AR, de Sousa FA, de Farias Santiago E, et al.
Phthalimido-thiazole as privileged scaffold: activity against immature and adult worms of Schistosoma
mansoni. Parasitol Res. 2018/05/08. 2018; 117: 2105–2115. https://doi.org/10.1007/s00436-018-5897-
4
PMID: 29736731
18. Kubba AARM Abbas SS. Synthesis and antimicrobial evaluation of new derivatives derived from-2-
amino-4-(4-nitro-/4-bromo-phenyl thiazole). Res J Pharm Biol Chem Sci. 2018; 9: 235–242.
19. Mohareb RM, Abdallah AEM, Ahmed EA. Synthesis and cytotoxicity evaluation of thiazole derivatives
obtained from 2-amino-4,5,6,7-tetrahydrobenzo[b]thiophene- 3-carbonitrile. Acta Pharm. 2018/01/18.
2017; 67: 495–510. https://doi.org/10.1515/acph-2017-0040 PMID: 29337677
2
2
2
0. Ouf SA, Gomha SM, Ewies MM, Sharawy IAA. Synthesis, Characterization, and Antifungal Activity
Evaluation of Some Novel Arylazothiazoles. J Heterocycl Chem. 2018; 55: 258–264. https://doi.org/10.
1002/jhet.3040
1. Santiago EF, de Oliveira SA, de Oliveira Filho GB, Moreira DR, Gomes PA, da Silva AL, et al. Evalua-
tion of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles. Antimicrob Agents
Chemother. 2013/10/30. 2014; 58: 352–363. https://doi.org/10.1128/AAC.01900-13 PMID: 24165185
2. Reddy GT, Kumar G, Reddy NCG. Water-Mediated One-pot Three-Component Synthesis of Hydrazi-
nyl-Thiazoles Catalyzed by Copper Oxide Nanoparticles Dispersed on Titanium Dioxide Support: A
Green Catalytic Process. Adv Synth Catal. 2018; 360: 995–1006. https://doi.org/10.1002/adsc.
201701063
2
3. Mazzone G, Pignatello R, Panico A, Mazzone S, Puglisi G, Pennisi G, et al. MAOI activity of some
novel series of substituted thiazol-2-yl-hydrazines. Pharmazie. 1992/12/01. 1992; 47: 902–910. Avail-
able: http://www.ncbi.nlm.nih.gov/pubmed/1293612 PMID: 1293612
24. Popova ZI, Tsurkan AA, Steblyuk PN. Synthesis and biological activity of some phenylazothiazoles.
Farmatsevtichnii Zhurnal. 1985; 6: 41–44.
25. de Oliveira Filho GB, Cardoso MVO, Espindola JWP, Oliveira ESDA, Ferreira RS, Coelho PL, et al.
Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
20 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
Eur J Med Chem. 2017/10/17. 2017; 141: 346–361. S0223-5234(17)30762-6 [pii] https://doi.org/10.
1016/j.ejmech.2017.09.047 PMID: 29031078
2
2
2
2
6. Lewis FA, Tucker MS. Schistosomiasis. 2014. pp. 47–75. https://doi.org/10.1007/978-1-4939-0915-5_3
PMID: 24903363
7. Duvall RH, DeWitt WB. An improved perfusion technique for recovering adult schistosomes from labo-
ratory animals. Am J Trop Med Hyg. 1967; https://doi.org/10.4269/ajtmh.1967.16.483 PMID: 4952149
8. Basch PF. Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and
development until pairing. J Parasitol. 1981; https://doi.org/10.2307/3280632
9. Horiuchi A, Satou T, Akao N, Koike K, Fujita K, Nikaido T. The effect of free and polyethylene glycol-lipo-
some-entrapped albendazole on larval mobility and number in Toxocara canis infected mice. Vet Para-
sitol. 2005; https://doi.org/10.1016/j.vetpar.2004.12.017 PMID: 15817207
3
3
3
3
3
3
3
3
0. Panic G, Flores D, Ingram-Sieber K, Keiser J. Fluorescence/luminescence-based markers for the
assessment of Schistosoma mansoni schistosomula drug assays. Parasites and Vectors. 2015; https://
doi.org/10.1186/s13071-015-1233-3 PMID: 26644133
1. Peak E, Chalmers IW, Hoffmann KF. Development and validation of a quantitative, High-throughput,
Fluorescent-based bioassay to detect schistosoma viability. PLoS Negl Trop Dis. 2010; https://doi.org/
10.1371/journal.pntd.0000759 PMID: 20668553
2. Almeida GT, Lage RCG, Anderson L, Venancio TM, Nakaya HI, Miyasato PA, et al. Synergy of Omep-
razole and Praziquantel In Vitro Treatment against Schistosoma mansoni Adult Worms. PLoS Negl
Trop Dis. 2015; 9: 1–23. https://doi.org/10.1371/journal.pntd.0004086 PMID: 26402251
3. Desai NN, Kennard EA, Kniss DA, Friedman CI. Novel human endometrial cell line promotes blastocyst
development. Fertil Steril. 1994/04/01. 1994; 61: 760–766. Available: https://www.ncbi.nlm.nih.gov/
pubmed/7512055 PMID: 7512055
4. Storey DM, Ogbogu VC. Observations on third-stage larvae and adults of Litomosoides carinii (Nema-
toda: Filarioidea) by scanning and transmission electron microscopy. Ann Trop Med Parasitol. 1991;
https://doi.org/10.1080/00034983.1991.11812537 PMID: 1888208
5. Cogswell AA, Kommer VP, Williams DL. Transcriptional analysis of a unique set of genes involved in
Schistosoma mansoni female reproductive biology. PLoS Negl Trop Dis. 2012/11/21. 2012; 6: e1907.
https://doi.org/10.1371/journal.pntd.0001907 [pii] PMID: 23166854
6. Pereira R V., Gomes MDS, Olmo RP, Souza DM, Cabral FJ, Jannotti-Passos LK, et al. Ubiquitin-spe-
cific proteases are differentially expressed throughout the Schistosoma mansoni life cycle. Parasites
and Vectors. 2015; https://doi.org/10.1186/s13071-015-0957-4 PMID: 26112833
7. Farias LP, Tararam CA, Miyasato PA, Nishiyama MY, Oliveira KC, Kawano T, et al. Screening the
Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in
search for vaccine candidates. Parasitol Res. 2011; https://doi.org/10.1007/s00436-010-2045-1 PMID:
20852890
3
8. Pereira ASA, Amaral MS, Vasconcelos EJR, Pires DS, Asif H, daSilva LF, et al. Inhibition of histone
methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and
decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism.
PLoS Negl Trop Dis. 2018; 12: e0006873. Available: https://doi.org/10.1371/journal.pntd.0006873
PMID: 30365505
3
9. Anderson L, Gomes MR, daSilva LF, Pereira A da SA, Mourão MM, Romier C, et al. Histone deacety-
lase inhibition modulates histone acetylation at gene promoter regions and affects genome-wide gene
transcription in Schistosoma mansoni. PLoS Negl Trop Dis. 2017; https://doi.org/10.1371/journal.pntd.
0005539 PMID: 28406899
4
0. Marek M, Kannan S, Hauser AT, Moraes Mourao M, Caby S, Cura V, et al. Structural basis for the inhi-
bition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma man-
soni. PLoS Pathog. 2013/10/03. 2013; 9: e1003645. https://doi.org/10.1371/journal.ppat.1003645 [pii]
PMID: 24086136
41. Wang J, Collins 3rd JJ. Identification of new markers for the Schistosoma mansoni vitelline lineage. Int J
Parasitol. 2016/04/09. 2016; 46: 405–410. https://doi.org/10.1016/j.ijpara.2016.03.004 PMID:
27056273
4
2. Utzinger J, Raso G, Brooker S, De Savigny D, Tanner M, Ornbjerg N, et al. Schistosomiasis and
neglected tropical diseases: towards integrated and sustainable control and a word of caution. Parasi-
tology. 2009/11/13. 2009; 136: 1859–1874. https://doi.org/10.1017/S0031182009991600 PMID:
19906318
43. Carvalho OS, Coelho PMZ, Lenzi LH. Terapêutica experimental da esquistossomose mansoni. Schis-
tosoma mansoni e esquistossomose: uma visão multidisciplinar. Rio de Janeiro: Editora Fiocruz;
2008. pp. 822–847.
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
21 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
4
4. de Oliveira RN, Rehder VL, Santos Oliveira AS, Junior IM, de Carvalho JE, de Ruiz AL, et al. Schisto-
soma mansoni: in vitro schistosomicidal activity of essential oil of Baccharis trimera (less) DC. Exp
Parasitol. 2012/07/10. 2012; 132: 135–143. https://doi.org/10.1016/j.exppara.2012.06.005 PMID:
22771865
4
5. Moraes J, Nascimento C, Lopes PO, Nakano E, Yamaguchi LF, Kato MJ, et al. Schistosoma mansoni:
In vitro schistosomicidal activity of piplartine. Exp Parasitol. 2010/09/14. 2011; 127: 357–364. https://
doi.org/10.1016/j.exppara.2010.08.021 PMID: 20832410
46. Palusiak M, Grabowski SJ. Methoxy group as an acceptor of proton in hydrogen bonds. J Mol Struct.
2002; https://doi.org/10.1016/S0022-2860(02)00406–4
4
7. Sović I, Cindrić M, Perin N, Boček I, Novaković I, Damjanović A, et al. Biological Potential of Novel
Methoxy and Hydroxy Substituted Heteroaromatic Amides Designed as Promising Antioxidative
Agents: Synthesis, 3D-QSAR Analysis, and Biological Activity. Chem Res Toxicol. 2019; https://doi.org/
10.1021/acs.chemrestox.9b00256 PMID: 31381319
4
8. Kumar R, Mohanakrishnan D, Sharma A, Kaushik NK, Kalia K, Sinha AK, et al. Reinvestigation of struc-
ture-activity relationship of methoxylated chalcones as antimalarials: synthesis and evaluation of 2,4,5-
trimethoxy substituted patterns as lead candidates derived from abundantly available natural beta-asar-
one. Eur J Med Chem. 2010/09/25. 2010; 45: 5292–5301. https://doi.org/10.1016/j.ejmech.2010.08.
049 PMID: 20863599
4
5
5
9. Bello ML, Chiaradia LD, Dias LR, Pacheco LK, Stumpf TR, Mascarello A, et al. Trimethoxy-chalcone
derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular model-
ing and structure-activity relationship (SAR). Bioorg Med Chem. 2011/07/16. 2011; 19: 5046–5052.
https://doi.org/10.1016/j.bmc.2011.06.023 PMID: 21757358
0. Bernardes LS, Kato MJ, Albuquerque S, Carvalho I. Synthesis and trypanocidal activity of 1,4-bis-
(
3,4,5-trimethoxy-phenyl)-1,4-butanediol and 1,4-bis-(3,4-dimethoxyphenyl)-1,4-butanediol. Bioorg
Med Chem. 2006/08/16. 2006; 14: 7075–7082. https://doi.org/10.1016/j.bmc.2006.07.006 PMID:
6908164
1
1. Papadopoulou M V, Bloomer WD, Rosenzweig HS, Wilkinson SR, Szular J, Kaiser M. Antitrypanosomal
activity of 5-nitro-2-aminothiazole-based compounds. Eur J Med Chem. 2016/04/20. 2016; 117: 179–
186. https://doi.org/10.1016/j.ejmech.2016.04.010 PMID: 27092415
52. Paula FR, Serrano SHP, Tavares LC. Aspects of Bioactivity and Toxicity of Nitrocompounds. Quim
Nova. 2009; 32: 1013–1020. https://doi.org/10.1590/S0100-40422009000400032
5
3. Gillis EP, Eastman KJ, Hill MD, Donnelly DJ, Meanwell NA. Applications of Fluorine in Medicinal Chem-
istry. J Med Chem. 2015/07/23. 2015; 58: 8315–8359. https://doi.org/10.1021/acs.jmedchem.5b00258
PMID: 26200936
5
4. Altintop MD, Atli O, Ilgin S, Demirel R, Ozdemir A, Kaplancikli ZA. Synthesis and biological evaluation of
new naphthalene substituted thiosemicarbazone derivatives as potent antifungal and anticancer
agents. Eur J Med Chem. 2015/12/27. 2016; 108: 406–414. https://doi.org/10.1016/j.ejmech.2015.11.
0
41 PMID: 26706351
5. Greenberg RM. Are Ca2+ channels targets of praziquantel action? Int J Parasitol. 2004/12/28. 2005;
5: 1–9. https://doi.org/10.1016/j.ijpara.2004.09.004 PMID: 15619510
5
5
3
6. Harder A, Goossens J, Andrews P. Influence of praziquantel and Ca2+ on the bilayer-isotropic-hexago-
nal transition of model membranes. Mol Biochem Parasitol. 1988/05/01. 1988; 29: 55–59. Available:
https://www.ncbi.nlm.nih.gov/pubmed/3386687 https://doi.org/10.1016/0166-6851(88)90119-3 PMID:
3386687
5
7. Lima SF, Vieira LQ, Harder A, Kusel JR. Effects of culture and praziquantel on membrane fluidity
parameters of adult Schistosoma mansoni. Parasitology. 1994/07/01. 1994; 109 (Pt 1): 57–64. Avail-
able: https://www.ncbi.nlm.nih.gov/pubmed/8058369
5
5
6
8. Craig PN. Interdependence between Physical Parametess and Selection of Substituent Groups for Cor-
relation Studies. J Med Chem. 1971; https://doi.org/10.1021/jm00290a004 PMID: 5114063
9. Orrenius S, Zhivotovsky B, Nicotera P. Regulation of cell death: The calcium-apoptosis link. Nat Rev
Mol Cell Biol. 2003; 4: 552–565. https://doi.org/10.1038/nrm1150 PMID: 12838338
0. Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2+
transfer in the control of apoptosis. Oncogene. 2008/10/29. 2008; 27: 6407–6418. https://doi.org/10.
1038/onc.2008.308 PMID: 18955969
6
1. You H, McManus DP, Hu W, Smout MJ, Brindley PJ, Gobert GN. Transcriptional responses of in vivo
praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway mem-
ber CamKII. PLoS Pathog. 2013/04/05. 2013; 9: e1003254. https://doi.org/10.1371/journal.ppat.
1003254 PMID: 23555262
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
22 / 23

Activity evaluation of thiazole derivatives on Schistosoma mansoni
62. Marxer M, Ingram K, Keiser J. Development of an in vitro drug screening assay using Schistosoma hae-
matobium schistosomula. Parasit Vectors. 2012/08/11. 2012; 5: 165. https://doi.org/10.1186/1756-
3305-5-165 PMID: 22876861
6
3. Bertao HG, da Silva RAR, Padilha RJR, Albuquerque MCPA, Radis-Baptista G. Ultrastructural analysis
of miltefosine-induced surface membrane damage in adult Schistosoma mansoni BH strain worms.
Parasitol Res. 2012; 110: 2465–2473. https://doi.org/10.1007/s00436-011-2786-5 PMID: 22215191
6
6
6
6
4. Taha H, Soliman ML. Antischistosomal Activity of 3-Substituted-5-(2-Aryl-2-Oxoethyl) -2, 4-Dioxo-1, 3-
Thiazolidine (Ro-354). Int J Agric &BIOLOGY. 2007; 09: 87–93.
5. Mohamed SH, Fawzi SM. Scanning electron microscopy on adults of Schistosoma mansoni treated in
vivo with praziquantel and Ro-15(5458). Qatar Univ Sci J. 1997; 17: 439–458.
6. Fawzi SM. Ultrastructural studies on the effect of antischistosomal drug Ro15-5458 on the tegument of
male Schistosoma mansoni. Egypt Zool. 1999; 33: 21–31.
7. Manneck T, Haggenmuller Y, Keiser J. Morphological effects and tegumental alterations induced by
mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology. 2009/10/10.
2010; 137: 85–98. https://doi.org/10.1017/S0031182009990965 PMID: 19814844
6
8. Xiao S, Shen B, Utzinger J, Chollet J, Tanner M. Ultrastructural alterations in adult Schistosoma man-
soni caused by artemether. Mem Inst Oswaldo Cruz. 2002/09/10. 2002; 97: 717–724. Available: https://
www.ncbi.nlm.nih.gov/pubmed/12219141 https://doi.org/10.1590/s0074-02762002000500023 PMID:
12219141
6
7
7
9. Fitzpatrick JM, Hirai Y, Hirai H, Hoffmann KF. Schistosome egg production is dependent upon the activ-
ities of two developmentally regulated tyrosinases. FASEB J. 2006/12/15. 2007; 21: 823–835. https://
doi.org/10.1096/fj.06-7314com PMID: 17167065
0. Bobek LA, Rekosh DM, LoVerde PT. Small gene family encoding an eggshell (chorion) protein of the
human parasite Schistosoma mansoni. Mol Cell Biol. 1988/08/01. 1988; 8: 3008–3016. Available:
https://www.ncbi.nlm.nih.gov/pubmed/2850476 https://doi.org/10.1128/mcb.8.8.3008 PMID: 2850476
1. Chen LL, Rekosh DM, LoVerde PT. Schistosoma mansoni p48 eggshell protein gene: characterization,
developmentally regulated expression and comparison to the p14 eggshell protein gene. Mol Biochem
Parasitol. 1992/05/01. 1992; 52: 39–52. Available: https://www.ncbi.nlm.nih.gov/pubmed/1625706
https://doi.org/10.1016/0166-6851(92)90034-h PMID: 1625706
7
2. Nollen PM, Floyd RD, Kolzow RG, Deter DL. The timing of reproductive cell development and move-
ment in Schistosoma mansoni, S. japonicum, and S. haematobium, using techniques of autoradiogra-
phy and transplantation. J Parasitol. 1976/04/01. 1976; 62: 227–231. Available: https://www.ncbi.nlm.
nih.gov/pubmed/1263031 PMID: 1263031
73. Seydoux G, Braun RE. Pathway to totipotency: lessons from germ cells. Cell. 2006/11/30. 2006; 127:
891–904. https://doi.org/10.1016/j.cell.2006.11.016 PMID: 17129777
74. Wang Y, Zayas RM, Guo T, Newmark PA. nanos function is essential for development and regeneration
of planarian germ cells. Proc Natl Acad Sci U S A. 2007/03/23. 2007; 104: 5901–5906. https://doi.org/
10.1073/pnas.0609708104 PMID: 17376870
7
5. Wang YY, Stary JM, Wilhelm JE, Newmark PA. A functional genomic screen in planarians identifies
novel regulators of germ cell development. Genes Dev. 2010; 24: 2081–2092. https://doi.org/10.1101/
gad.1951010 PMID: 20844018
76. Ribeiro-dos-Santos G, Verjovski-Almeida S, Leite LC. Schistosomiasis—a century searching for che-
motherapeutic drugs. Parasitol Res. 2006/04/26. 2006; 99: 505–521. https://doi.org/10.1007/s00436-
006-0175-2 PMID: 16636847
PLOS ONE | https://doi.org/10.1371/journal.pone.0225425 November 25, 2019
23 / 23